Cardiovascular disease and atopic dermatitis: epidemiological strengths and limitations

Funding sources: No external funding.

Conflicts of interest: J.P.T. has attended advisory boards about atopic dermatitis for Roche, Eli Lilly and Sanofi-Genzyme, and been a speaker on atopic dermatitis for LEO Pharma and Sanofi-Genzyme. A.E. has received research funding from Pfizer, Eli Lilly, the Danish National Psoriasis Foundation and the Kgl Hofbundtmager Aage Bang Foundation, and honoraria as consultant and/or speaker from Almirall, LEO Pharma, Samsung Bioepis Co. Ltd, Pfizer, Eli Lilly, Novartis, Galderma and Janssen Pharmaceuticals.